Universe Pharmaceuticals to Implement Dual-Class Share Structure on Nasdaq

Universe Pharmaceuticals INC has announced the official implementation of a dual-class share structure on the Nasdaq Capital Market, following amendments to the company's memorandum and articles of association. The new structure is set to take effect on February 13, 2026, dividing the authorized share capital into Class A and Class B ordinary shares. Class A ordinary shares will continue to trade under the existing ticker symbol UPC. This restructuring is primarily a corporate governance move aimed at managing voting rights and long-term corporate control. Market analysts view this as a neutral development that does not directly impact the company's immediate financial performance or valuation. Investors will likely monitor how this change affects future decision-making processes within the pharmaceutical firm.